• Mariya Ivanova Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Varna, Bulgaria
  • Anna Todorova Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Varna, Bulgaria
  • Magdalena Pesheva Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Varna, Bulgaria




burnout, pharmacists, community pharmacy, COVID-19


Introduction: The community pharmacy is the most accessible medical facility in the current healthcare system. Therefore, the expectations from  pharmacists as the most accessible healthcare professionals are constantly rising. However, various studies indicate that pharmacists are subject to very high levels of occupational stress and professional burnout is common.

The COVID-19 pandemic has posed new challenges to the work organisation in pharmacies and demand for an adequate reorganisation. In addition, it forced pharmacists to quickly adapt to the new circumstances and requirements and further increased occupational stress. 

Objective: To establish the level of occupational burnout among community pharmacists during COVID-19.

Materials and Methods: An anonymous questionnaire survey was conducted among 127 pharmacists working in community pharmacies in Varna, Bulgaria. The study period was from March 2021 to October 2021. The questionnaire consisted of two parts; the first one was based on the specialised Maslach Burnout Inventory (MBI-HSS) tool, assessing professional burnout in terms of emotional exhaustion, depersonalisation, and personal accomplishment; the second one collected data about the demographic characteristics of the respondents, including their job position, pharmacy type (an independent pharmacy or a pharmacy chain) and information on specific problems during COVID-19.

Results: The identified mean values in the group of respondents were as follows: emotional exhaustion M=23.39 (SD 9,298), depersonalisation M=12.37 (SD 6,426), professional achievements M=31.25 (SD 7,531). The sample mean values that stood out were in the depersonalisation scale М=12.37, which is considered a high value.  A statistically significant difference was found in the different age groups on the depersonalisation scale (F=3,957, p=0,022). There was a statistically significant difference between the arithmetic mean values for the age groups 25-40 years (M=13.75) and over 55 years (M=9.86).

Conclusion:  Based on the statistical differences for depersonalisation among pharmacists in different age groups, it can be concluded that young pharmacists do not express empathy while providing pharmaceutical care services.


AMADSE(Act on the Measures and Actions During the State of Emergency)Declared with the Decision of the National Assembly of March 13th, 2020. https://www.cpdp.bg/en/index.php?p=element&aid=1244 [internet] Boyko V. (1999). Methodology for diagnosing the level of emotional burnout; In: D. Raygorodsky (edit.) Practical Psychodiagnostics: Methods and tests. Samara, 161-169.

Cohen (1988);Statistical Power Analisis for the Behavioral Science ISBN 0-8058-0283-5

Durham ME, Bush PW, Ball AM. ( 2018). Evidence of burnout in health-system pharmacists. American Journal of Health- System Pharmacy, 75(23 Supplement 4): S93-S100. DOI: 10.2146/ajhp170818. Epub; Oct 17. PMID: 30333113

Elbeddini A, Wen CX, Tayefehchamani Y, To A. (2020). Mental health issues impacting pharmacists during COVID-19. Journal of Pharmaceutical Policy and Practice, 13(1):46. [PMC free article] [PubMed] [Google Scholar]

FIP statement of principle; Impact of the COVID-19 pandemic on health equity, and vulnerable patients and populations 25 May 2020 https://www.fip.org/file/4497 [internet]

FIP: International Pharmaceutical Federation COVID-19: guidelines for pharmacists and the pharmacy workforce. https://www.fip.org/files/content/priority-areas/coronavirus/COVID-19- Guidelines-for-pharmacists-and-the-pharmacy-workforce.pdf Available from: Accessed date: 08.06.20.

Freudenberger H., Richelson G., (1980). Burn out: The high cost of high achievement. What it is and how to survive it. Bantam Books

Johnston K, O'Reilly C. L., Scholz B, Georgousopoulou EN, Mitchell I. (2021). Burnout and the challenges facing pharmacists during COVID-19: results of a national survey. International Journal of Clinical Pharmacy, 43(3),716-725. DOI: 10.1007/s11096-021-01268-5. Epub 2021 Apr 13. PMID: 33851288; PMCID: PMC8043093.

Health Act (provisions related with the anti-epidemic measures) in force since 11th December 2020) [internet]

Hedima EW, Okoro RN (2021). Telepharmacy: an opportunity for community pharmacists during the COVID-19 pandemic in Sub Saharan Africa. Health Policy and Technology, 10: 23. DOI: https://doi.org/10.1016/j.hlpt.2020.10.013

http://www.pgeu.eu, Pharmaceutical Group of European Union (2012)

Ivanova M., A. Todorova, L. Georgieva, I. Kumanov (2020); Burnout syndrome in pharmacists practicing in different fields of the pharmaceutical sector. Management and education,16(6),32-37 ISSN 13126121

Ivanova M, Todorova A, Georgieva L. (2020). Burnout syndrome in Bulgarian pharmacists: a pilot study; Proceedings of CBU in Medicine and Pharmacy, 1, 36-40. https://doi.org/10.12955/pmp.v1.95

Li, M., Razaki H., Mui, V., Rao, P., & Brocavich, S.(2020). The pivotal role of pharmacists during the 2019 coronavirus pandemic. Journal of the American Pharmacist Association, 60 (6) e73–5. DOI: https:// doi.org/10.1016/j.japh.2020.05.017

Maslach C, Schaufeli W, Leiter M (2001). Job burnout. Annual Review of Psychology, 52(1), 397-422.

Maslach, C., Jackson, S. E. (1981). The measurement of experienced burnout; Journal of Occupational Behaviour, 2, 99-113.

Maslach, C., & Jackson, S. E. (1986). Maslach Burnout Inventory Manual (3rd edition). Palo Alto, CA: Consulting Psychologists Press.

Mehta, S., Machado, F., Kwizera, A., Papazian, L., Moss, M., Azoulay, É, & Herridge, M. (2021). COVID-19: a heavy toll on health-care workers. The Lancet; Respiratory medicine, 9(3), 226–228. DOI: https://doi.org/10.1016/S2213-2600 (21)00068-0 [PubMed]

Nguy J, Hitchen SA, Hort AL et al.(2020). The role of a Coronavirus disease 2019 pharmacist: an Australian perspective. International Journal of Clinical Pharmacy, 42, 1379–84. DOI: https://doi.org/10.1007/s11096-020-01067-4

Ordinance No 4/4.03.2009 on the conditions and procedures for prescribing and dispensing of medicines; prom. SG 21/20th March 2009, amen. SG 94/12.11.2022

Pesheva M. Todorova A. Ivanova M. (2021); Challenges in work of pharmacists in a pharmacy, related to changes in regulations, in condition of emergency situation and COVID-19; 10: Suppl. 1. Proceedings from IX Scientific Session of Medical College of Varna, 355-3591; ISSN 1314-8338 (Print) ISSN 2367-5519

Pesheva М, Todorova А., Kumanov I., Ivanova M. (2021). Electronic prescribing – regulatory framework concerning masters of pharmacy, Management and Education 17 (6)18-23, Index: EBSCO

Sathvik B. Sridhar and Syed Arman Rabbani (2021). Pharmaceutical care services provided by pharmacists during COVID-19 pandemic: perspectives from around the World. Journal of Pharmaceutical Health Services Research, 12, 463–468 DOI: doi:10.1093/jphsr/rmab017

Strand MA, DiPietro Mager N. A. D., Hall L, Martin, S. L., & Sarpong, D. F. (2020). Pharmacy contributions to improved population health: expanding the public health roundtable. Preventing Chronic Disease, 17, E113. DOI: https://doi.org/10.5888/pcd17.200350

Tabur, A, Choudhury, A, Emhan, A, Mengenci, C, & Asan, O (2022). Clinicians' Social Support, Job Stress, and Intent to Leave Healthcare during COVID-19; Healthcare (Basel, Switzerland), 10(2), 229.DOI: https://doi.org/10.3390/healthcare10020229 [PubMed]

Tarpomanova Ts. Tosheva Y, Pavlova S. (2021). PHI’s workload as a communication factor in the workplace; Bulgarian Magazine on Public Health 13 (4), 104-114 2021/12

Tsenova B, Velkova D (1999). Psycho-social factors and stress in nurses; Hygiene problems; Vol. XX (1):23-31

Tsvetkova А., A. Todorova, V. Petkova (2014). Patients, pharmacists and physicians’ views on the use of over-the-counter-drugs. A comparative analysis. World journal of pharmacy and pharmaceutical sciences, 3(12), 01-09. ISSN 2278 – 4357

Tsvetkova А, А. Todorova, V. Petkova (2014). The role of the pharmacist as an advisor on responsible self-medication: a survey. World journal of pharmacy and pharmaceutical sciences, 3(11), 325-335. ISSN 2278 – 4357.

Visacri MB, Figueiredo IV, Lima TM (2021). Role of pharmacist during the COVID-19 pandemic: a scoping review. Research in Social and Administrative Pharmacy; 17, 1799–806. DOI: https://doi.org/10.1016/j.sapharm.2020.07.003




How to Cite

Ivanova, M. ., Todorova, A. ., & Pesheva, M. . (2022). OCCUPATIONAL BURNOUT SYNDROME AMONG COMMUNITY PHARMACISTS DURING COVID-19 PANDEMIC. Proceedings of CBU in Medicine and Pharmacy, 3, 6-12. https://doi.org/10.12955/pmp.v3.314
صندلی اداری سرور مجازی ایران Decentralized Exchange
فروشگاه اینترنتی صندلی اداری جوراب افزایش قد ژل افزایش قد